Frexalimab

Modify Date: 2024-09-17 22:16:13

Frexalimab structure	Common Name	Frexalimab
	CAS Number	2515463-86-0	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Frexalimab

Frexalimab (SAR441344; INX-021) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab has the potential for multiple sclerosis research[1].

Properties
Spectrum

Name	Frexalimab

Description	Frexalimab (SAR441344; INX-021) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab has the potential for multiple sclerosis research[1].
Related Catalog	Research Areas >> Inflammation/Immunology
References	[1]. Bruce A C Cree, et al. New drugs for multiple sclerosis: new treatment algorithms. Curr Opin Neurol. 2022 Jun 1;35(3):262-270.

No Any Chemical & Physical Properties

Frexalimab

Use of Frexalimab

Names

Frexalimab Biological Activity

Chemical & Physical Properties